Ethinamate and Methyprylone as Hypnotics: A Comparative Trial

1960 ◽  
Vol 106 (445) ◽  
pp. 1455-1458 ◽  
Author(s):  
I. C. Lodge Patch ◽  
M. D. Eilenberg ◽  
E. H. Hare

The use of barbiturates in the treatment of insomnia carries a constant risk of habituation and of fatal poisoning from suicidal or accidental overdose. For these reasons, new non-barbiturate hypnotics deserve the closest attention. Ethinamate (“Valmidate”) and methyprylone (“Noludar”) are two such drugs. No trial comparing the hypnotic efficacy of ethinamate with a barbiturate has yet been reported, though Gruber et al. (1954) found the day-time sedative effect of 500 mg. ethinamate to be less (in duration of action) than 100 mg. of quinalbarbitone sodium. Methyprylone has been compared with barbiturate by Stewart (1956) who found 200 mg. equivalent to 100 mg. of amylo- or butobarbitone, by Lasagna (1956) who found 250 mg. equivalent to 100 mg. of pento- or quinal-barbitone, and by Thomson (1958) who found 400 mg. equivalent to 100 mg. of quinalbarbitone.

1973 ◽  
Vol 1 (2) ◽  
pp. 417-421 ◽  
Author(s):  
B C Hovell ◽  
A E Ward

In a comparative trial, buprenorphine 0.3 mg or morphine 10 mg was administered intramuscularly to patients post operatively. The new drug buprenorphine produced more pain relief than morphine and appeared to have a longer duration of action. The side-effects produced by the two drugs were similar, as were the effects on respiratory and cardiovascular measurements.


1969 ◽  
Vol 61 (1_Suppl) ◽  
pp. S108
Author(s):  
Jan L. Mulder ◽  
Olof de Maré ◽  
Per Axel Heedman
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document